Pentoxifylline added to standard care for mild-to-moderate plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests whether adding pentoxifylline (a pill that improves blood flow and reduces inflammation) to your usual topical treatments can help clear mild-to-moderate plaque psoriasis. If you have had psoriasis for a while and it covers 3-10% of your body, this study might offer a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have mild-to-moderate plaque psoriasis covering 3–10% of your body (as confirmed by a doctor).
- You have been using the same topical treatments for at least 2 weeks before joining.
- You have not used biologic medications (like Humira or Stelara) in the past 12 weeks.
- You are not pregnant or breastfeeding.
- You do not have severe liver or kidney disease, a bleeding disorder, or are not taking blood thinners that cannot be managed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This trial tests a new study drug called HSK44459 for people with moderate to severe plaque psoriasis. The hope is that the drug can reduce psoriasis symptoms and improve quality of life. Participation involves receiving the study drug and being monitored for safety and effectiveness.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This Phase 1 study tests a new drug (SFA002) in adults with stable plaque psoriasis. It mainly focuses on safety and how the body responds, and may eventually help people with psoriasis plaques.
This study compares two oral pill treatments—methotrexate and tofacitinib—for people with chronic plaque psoriasis that is moderate to severe and hasn't responded well to creams. The goal is to see which pill works better at clearing skin.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.